新闻|股票|评论|外汇|债券|基金|期货|黄金|银行|保险|数据|行情|信托|理财|区块链|汽车|房产|科技|视频|博客
|直播|财道
|农金

简称:浙江医药 代码:600216


会计年度:2002-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
抵销1,913,200.001,913,200.00----
食品4,029,400.003,040,400.00989,000.0024.54
原料药426,304,100.00363,628,200.0062,675,900.0014.70
制剂药185,030,100.00121,890,600.0063,139,500.0034.12

会计年度:2001-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计867,037,700.00648,140,500.00--25.24
减:抵销4,641,800.004,641,800.00----
食品销售8,207,000.005,902,500.002,304,500.0028.07
原料药销售458,209,800.00413,876,800.0044,333,000.009.67
制剂药销售405,262,700.00233,002,900.00172,259,800.0042.50

    9/9 转到